Cargando…
MSX1—A Potential Marker for Uterus-Preserving Therapy of Endometrial Carcinomas
Prognostic factors are of great interest in patients with endometrial cancer. One potential factor could be the protein MSX1, a transcription repressor, that has an inhibitory effect on the cell cycle. For this study, endometrioid endometrial carcinomas (n = 53), clear cell endometrial carcinomas (n...
Autores principales: | Eppich, Simon, Kuhn, Christina, Schmoeckel, Elisa, Mayr, Doris, Mahner, Sven, Jeschke, Udo, Gallwas, Julia, Heidegger, Helene Hildegard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350265/ https://www.ncbi.nlm.nih.gov/pubmed/32630554 http://dx.doi.org/10.3390/ijms21124529 |
Ejemplares similares
-
MSX1-expression during the different phases in healthy human endometrium
por: Eppich, Simon, et al.
Publicado: (2023) -
Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients †
por: Schulz, Heiko, et al.
Publicado: (2017) -
Lysine-specific histone demethylase 1A (LSD1) in cervical cancer
por: Beilner, Daniel, et al.
Publicado: (2020) -
Higher CCL22+ Cell Infiltration is Associated with Poor Prognosis in Cervical Cancer Patients
por: Wang, Qun, et al.
Publicado: (2019) -
Overall Survival of Ovarian Cancer Patients Is Determined by Expression of Galectins-8 and -9
por: Schulz, Heiko, et al.
Publicado: (2018)